Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥436.6bn2023-04-01 → 2023-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥228.9bn2023-07-01 → 2023-09-30dCons.Revenue IFRS (5-year summary)
Revenue¥881.9bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥417.1bn2022-04-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥224.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS (5-year summary)
Operating income¥4.8bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥17.7bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥93.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥49.1bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax−¥958m2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥20.7bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥182.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥89.3bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥216.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥24.3bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥143.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥66.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥216.7bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥24.0bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥66.9bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥1.62Tat 2023-09-30Cons.Assets IFRS
Total assets¥1.51Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.49Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥790.2bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥867.1bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥827.5bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥641.2bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥644.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥827.5bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥640.1bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥643.0bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥488.2bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥169.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥297.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥11.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥98.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥412.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥58.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥15.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥125.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥143.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥35.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥173.812023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-19.642023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥113.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥52.52022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.972022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥173.432023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-19.62023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.082022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥52.452022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.932022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio51.2%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥18.6bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30¥50.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥28.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥23.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥4.3bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥68.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-09-30−¥788m
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.8bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥97.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 781
ItemContextValueUnit
Other income IFRSCurrentYTDDuration2549000000JPY
Other expenses IFRSPrior1YTDDuration5128000000JPY
Other expenses IFRSCurrentYTDDuration64330000000JPY
Operating profit loss IFRSPrior1YTDDuration93603000000JPY
Operating profit loss IFRSCurrentYTDDuration4789000000JPY
Finance income IFRSPrior1YTDDuration1764000000JPY
Finance income IFRSCurrentYTDDuration1247000000JPY
Finance costs IFRSPrior1YTDDuration6046000000JPY
Finance costs IFRSCurrentYTDDuration6994000000JPY
Profit loss before tax IFRSPrior1YTDDuration89321000000JPY
Profit loss before tax IFRSCurrentYTDDuration-958000000JPY
Income tax expense IFRSPrior1YTDDuration19795000000JPY
Income tax expense IFRSCurrentYTDDuration10532000000JPY
Profit loss from continuing operations IFRSPrior1YTDDuration69526000000JPY
Profit loss from continuing operations IFRSCurrentYTDDuration-11490000000JPY
Profit loss from discontinued operations IFRSPrior1YTDDuration-2586000000JPY
Profit loss from discontinued operations IFRSCurrentYTDDuration228149000000JPY
Profit loss IFRSPrior1YTDDuration66940000000JPY
Profit loss IFRSCurrentYTDDuration216659000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration66836000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration216296000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration104000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration363000000JPY
Profit loss IFRSPrior1YTDDuration66940000000JPY
Profit loss IFRSCurrentYTDDuration216659000000JPY
Continuing operations basic earnings loss per share IFRSPrior1YTDDuration54.53
Continuing operations basic earnings loss per share IFRSCurrentYTDDuration-9.53
Discontinued operations basic earnings loss per share IFRSPrior1YTDDuration-2.03
Discontinued operations basic earnings loss per share IFRSCurrentYTDDuration183.34
Basic earnings loss per share IFRSPrior1YTDDuration52.50
Basic earnings loss per share IFRSCurrentYTDDuration173.81
Continuing operations diluted earnings loss per share IFRSPrior1YTDDuration54.48
Continuing operations diluted earnings loss per share IFRSCurrentYTDDuration-9.50
Discontinued operations diluted earnings loss per share IFRSPrior1YTDDuration-2.03
Discontinued operations diluted earnings loss per share IFRSCurrentYTDDuration182.93
Diluted earnings loss per share IFRSPrior1YTDDuration52.45
Diluted earnings loss per share IFRSCurrentYTDDuration173.43
Net sales IFRSPrior1QuarterDuration224795000000JPY
Net sales IFRSCurrentQuarterDuration228921000000JPY
Cost of sales IFRSPrior1QuarterDuration72990000000JPY
Cost of sales IFRSCurrentQuarterDuration77710000000JPY
Gross profit IFRSPrior1QuarterDuration151805000000JPY
Gross profit IFRSCurrentQuarterDuration151211000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration102517000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration112863000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration334000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration-45000000JPY
Other income IFRSPrior1QuarterDuration1530000000JPY
Other income IFRSCurrentQuarterDuration1913000000JPY
Other expenses IFRSPrior1QuarterDuration2070000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass